Hedgehog signaling activation in the development of squamous cell carcinoma and adenocarcinoma of esophagus

International Journal of Biochemistry and Molecular Biology

Volumn 3, Issue 1, 2012, Pages 46-57

  Yang, Ling ^a,b,c   Wang, Li Shu ^d   Gatalica, Zoran ^f   Qiu, Suimin ^g   Liu, Zhihua ^h   Stoner, Gary ^d   Zhang, Hongwei ^b   Weiss, Heidi ⁱ   Xie, Jingwu ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHANDONG UNIVERSITY   (China)

^c INNER MONGOLIA MEDICAL COLLEGE   (China)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e Luke)   (United States)

^f CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^g University of Texas Medical Branch School of Medicine   (United States)

^h CANCER HOSPITAL   (China)

ⁱ UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Barrett's esophagus (BE); Esophageal adenocarcinoma (EAC); Esophageal squamous cell carcinoma (ESCC); Gli2; Hedgehog (Hh); Human homologue of hedgehog interaction protein (HHIP); Patched 1 (PTCH1 for humans and ptch1 for animals); Rat model; sFRP 1

Indexed keywords

BIOLOGICAL MARKER; PROTEIN PATCHED 1;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BARRETT ESOPHAGUS; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; DISEASE SEVERITY; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; GENETIC ANALYSIS; HEDGEHOG GENE; HUMAN; HUMAN TISSUE; MALE; MOLECULAR PATHOLOGY; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TUMOR DIFFERENTIATION; TUMOR GENE;

ANIMALIA; ERINACEIDAE; RATTUS;

EID: 84859699215     PISSN: None     EISSN: 21524114     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Jemal A, Siegel R, Xu J and Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Brown LM, Devesa SS and Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 2008; 100: 1184-1187.
3. He YT, Hou J, Chen ZF, Qiao CY, Song GH, Meng FS, Jin HX and Chen C. Decrease in the esophageal cancer incidence rate in mountainous but not level parts of Cixian County, China, over 29 years. Asian Pac J Cancer Prev 2005; 6: 510-514.
4. Ma X, Chen K, Huang S, Zhang X, Adegboyega PA, Evers BM, Zhang H and Xie J. Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas. Carcino- genesis 2005; 26: 1698-1705.
5. Nusslein-Volhard C, Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature 1980; 287: 795-801.
6. Toftgard R. Hedgehog signalling in cancer. Cell Mol Life Sci 2000; 57: 1720-1731.
7. Rubin LL, de Sauvage FJ. Targeting the Hedge-hog pathway in cancer. Nat Rev Drug Discov 2006; 5: 1026-1033.
8. Hooper JE, Scott MP. Communicating with Hedgehogs. Nat Rev Mol Cell Biol 2005; 6: 306-317.
9. Kinzler KW, Vogelstein B. The GLI gene encodes a nuclear protein which binds specific sequences in the human genome. Mol Cell Biol 1990; 10: 634-642.
10. Sasaki H, Hui C, Nakafuku M and Kondoh H. A binding site for Gli proteins is essential for HNF-3beta floor plate enhancer activity in transgenics and can respond to Shh in vitro. Development 1997; 124: 1313-1322.
11. Xie J. Hedgehog signaling pathway: development of antagonists for cancer therapy. Curr Oncol Rep 2008; 10: 107-113.
12. Fukaya M, Isohata N, Ohta H, Aoyagi K, Ochiya T, Saeki N, Yanagihara K, Nakanishi Y, Taniguchi H, Sakamoto H, Shimoda T, Nimura Y, Yoshida T and Sasaki H. Hedgehog signal activation in gastric pit cell and in diffuse-type gastric cancer. Gastroenterology 2006; 131: 14-29.
13. Lee SY, Han HS, Lee KY, Hwang TS, Kim JH, Sung IK, Park HS, Jin CJ and Choi KW. Sonic hedgehog expression in gastric cancer and gastric adenoma. Oncol Rep 2007; 17: 1051-1055.
14. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernandez-del Castillo C, Yajnik V, Antoniu B, McMahon M, Warshaw AL and Hebrok M. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003; 425: 851-856.
15. Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K, Parker AR, Shimada Y, Eshleman JR, Watkins DN and Beachy PA. Widespread requirement for Hedgehog ligand stimulation in growth of di- gestive tract tumours. Nature 2003; 425: 846-851.
16. Sheng T, Li C, Zhang X, Chi S, He N, Chen K, McCormick F, Gatalica Z and Xie J. Activation of the hedgehog pathway in advanced prostate cancer. Mol Cancer 2004; 3: 29.
17. Sanchez P, Hernandez AM, Stecca B, Kahler AJ, DeGueme AM, Barrett A, Beyna M, Datta MW, Datta S and Ruiz i Altaba A. Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. Proc Natl Acad Sci USA 2004; 101: 12561-12566.
18. Karhadkar SS, Bova GS, Abdallah N, Dhara S, Gardner D, Maitra A, Isaacs JT, Berman DM and Beachy PA. Hedgehog signalling in pros- tate regeneration, neoplasia and metastasis. Nature 2004; 431: 707-712.
19. Ma X, Sheng T, Zhang Y, Zhang X, He J, Huang S, Chen K, Sultz J, Adegboyega PA, Zhang H and Xie J. Hedgehog signaling is activated in subsets of esophageal cancers. Int J Cancer 2006; 118: 139-148.
20. Xie K, Abbruzzese JL. Developmental biology informs cancer: the emerging role of the hedgehog signaling pathway in upper gastrointestinal cancers. Cancer Cell 2003; 4: 245-247.
21. Mori Y, Okumura T, Tsunoda S, Sakai Y and Shimada Y. Gli-1 expression is associated with lymph node metastasis and tumor progression in esophageal squamous cell carcinoma. Oncology 2006; 70: 378-389.
22. Wang DH, Clemons NJ, Miyashita T, Dupuy AJ, Zhang W, Szczepny A, Corcoran-Schwartz IM, Wilburn DL, Montgomery EA, Wang JS, Jenkins NA, Copeland NA, Harmon JW, Phillips WA and Watkins DN. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia. Gastroenterology 2010; 138: 1810-1822.
23. Chen X, Yang G, Ding WY, Bondoc F, Curtis SK and Yang CS. An esophagogastroduodenal anastomosis model for esophageal adenocar- cinogenesis in rats and enhancement by iron overload. Carcinogenesis 1999; 20: 1801-1808.
24. Wang LS, Hecht SS, Carmella SG, Yu N, Larue B, Henry C, McIntyre C, Rocha C, Lechner JF and Stoner GD. Anthocyanins in black raspberries prevent esophageal tumors in rats. Cancer Prev Res (Phila) 2009; 2: 84-93.
25. Yang L, Bian Y, Huang S, Ma X, Zhang C, Su X, Chen ZJ, Xie J and Zhang H. Identification of signature genes for detecting hedgehog path- way activation in esophageal cancer. Pathol Oncol Res 2011; 17: 387-391.
26. Choi SS, Omenetti A, Witek RP, Moylan CA, Syn WK, Jung Y, Yang L, Sudan DL, Sicklick JK, Michelotti GA, Rojkind M and Diehl AM. Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibro- blastic transformation of rat hepatic cells in culture and cirrhosis. Am J Physiol Gastrointest Liver Physiol 2009; 297: G1093-1106.
27. Alexaki VI, Javelaud D, Van Kempen LC, Mohammad KS, Dennler S, Luciani F, Hoek KS, Juarez P, Goydos JS, Fournier PJ, Sibon C, Bertolotto C, Verrecchia F, Saule S, Delmas V, Ballotti R, Larue L, Saiag P, Guise TA and Mauviel A. GLI2-mediated melanoma invasion and metastasis. J Natl Cancer Inst 2010; 102: 1148-1159.
28. Stoner GD, Gupta A. Etiology and chemopre-vention of esophageal squamous cell carcinoma. Carcinogenesis 2001; 22: 1737-1746.
29. McManus DT, Olaru A and Meltzer SJ. Bio-markers of esophageal adenocarcinoma and Barrett's esophagus. Cancer Res 2004; 64: 1561-1569.
30. Wang DH, Souza RF. Biology of Barrett's esophagus and esophageal adenocarcinoma. Gastrointest Endosc Clin N Am 2011; 21: 25-38.
31. Chen X, Li N, Wang S, Hong J, Fang M, Yous-selfson J, Yang P, Newman RA, Lubet RA and Yang CS. Aberrant arachidonic acid metabo- lism in esophageal adenocarcinogenesis, and the effects of sulindac, nordihydroguaiaretic acid, and alpha-difluoromethylornithine on tumorigenesis in a rat surgical model. Carcinogenesis 2002; 23: 2095-2102.
32. Lin J, Beerm DG. Molecular biology of upper gastrointestinal malignancies. Semin Oncol 2004; 31: 476-486.
33. Okano J, Snyder L and Rustgi AK. Genetic alterations in esophageal cancer. Methods Mol Biol 2003; 222: 131-145.
34. McManus DT, Olaru A and Meltzer SJ. Bio-markers of esophageal adenocarcinoma and Barrett's esophagus. Cancer Research 2004; 64: 1561-1569.
35. Mandard AM, Hainaut P and Hollstein M. Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res 2000; 462: 335-342.
36. Moyes LH, Going JJ. Still waiting for predictive biomarkers in Barrett's oesophagus. J Clin Pathol 2011; 64: 742-750.
37. Hormi-Carver K, Souza RF. Molecular markers and genetics in cancer development. Surg Oncol Clin N Am 2009; 18: 453-467.
38. Yang L, Xie G, Fan Q and Xie J. Activation of the hedgehog-signaling pathway in human cancer and the clinical implications. Oncogene 2010; 29: 469-481.
39. Carey K. Hedgehog inhibitor single arm. Nat Biotechnol 2011; 29: 957.
40. Snijders AM, Huey B, Connelly ST, Roy R, Jordan RC, Schmidt BL and Albertson DG. Stro- mal control of oncogenic traits expressed in response to the overexpression of GLI2, a pleiotropic oncogene. Oncogene 2009; 28: 625-637.
41. Taniguchi H, Yamamoto H, Akutsu N, Nosho K, Adachi Y, Imai K and Shinomura Y. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer. J Pathol 2007; 213: 131-139.
42. Chi S, Huang S, Li C, Zhang X, He N, Bhutani MS, Jones D, Castro CY, Logrono R, Haque A, Zwischenberger J, Tyring SK, Zhang H and Xie J. Activation of the hedgehog pathway in a subset of lung cancers. Cancer Lett 2006; 244: 53-60.
43. He J, Sheng T, Stelter AA, Li C, Zhang X, Sinha M, Luxon BA and Xie J. Suppressing Wnt signaling by the hedgehog pathway through sFRP -1. J Biol Chem 2006; 281: 35598-35602.
44. Adolphe C, Hetherington R, Ellis T and Wainwright B. Patched1 functions as a gatekeeper by promoting cell cycle progression. Cancer Res 2006; 66: 2081-2088.